VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $505,000 | +10.3% | 40,000 | -20.0% | 0.02% | -12.0% |
| Q1 2020 | $458,000 | -66.3% | 50,000 | 0.0% | 0.02% | -60.3% |
| Q2 2019 | $1,361,000 | -62.6% | 50,000 | -73.7% | 0.06% | -62.5% |
| Q1 2019 | $3,635,000 | +103.6% | 189,927 | 0.0% | 0.17% | +95.3% |
| Q4 2018 | $1,785,000 | -47.6% | 189,927 | +5.6% | 0.09% | -44.2% |
| Q3 2018 | $3,404,000 | -0.4% | 179,927 | +2.9% | 0.15% | +14.1% |
| Q2 2018 | $3,418,000 | +4.0% | 174,927 | 0.0% | 0.14% | +1.5% |
| Q1 2018 | $3,287,000 | -25.3% | 174,927 | -34.0% | 0.13% | -21.3% |
| Q4 2017 | $4,398,000 | +29.5% | 264,927 | +60.6% | 0.17% | +32.0% |
| Q3 2017 | $3,396,000 | +110.5% | 164,927 | -8.4% | 0.13% | +120.7% |
| Q2 2017 | $1,613,000 | +10.8% | 180,000 | +63.6% | 0.06% | +18.4% |
| Q1 2017 | $1,456,000 | +14.3% | 110,000 | +10.0% | 0.05% | +4.3% |
| Q4 2016 | $1,274,000 | – | 100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |